Merck & Co. Continues Oncology Expansion with US$2.75 B VelosBio Buy

By Michelle Liu

Pharma Deals Review: Vol 2020 Issue 11 (Table of Contents)

Published: 17 Nov-2020

DOI: 10.3833/pdr.v2020.i11.2569     ISSN: 1756-7874

Section: Mergers & Acquisitions



In another multibillion-dollar effort to bolster its oncology portfolio, Merck & Co...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details